Ptgx stock price today stock
WebMar 29, 2024 · Complete Protagonist Therapeutics Inc. stock information by Barron's. View real-time PTGX stock price and news, along with industry-best analysis. Web2 days ago · Analyst Forecast. According to 12 analysts, the average rating for PTGX stock is "Buy." The 12-month stock price forecast is $34.88, which is an increase of 82.33% from …
Ptgx stock price today stock
Did you know?
WebApr 8, 2024 · Protagonist Therapeutics, Inc. ( NASDAQ:PTGX – Get Rating )’s share price traded up 3.9% during trading on Thursday . The company traded as high as $18.73 and last traded at $18.73. 149,427 shares were traded during mid-day trading, a decline of 91% from the average session volume of 1,652,346 shares. The stock had previously closed at … WebApr 11, 2024 · View Protagonist Therapeutics, Inc PTGX investment & stock information. Get the latest Protagonist Therapeutics, Inc PTGX detailed stock quotes, stock data, Real …
WebSep 17, 2024 · Here's what has PTGX stock dropping today. By Chris MacDonald, InvestorPlace Contributor Sep 17, 2024, 4:29 pm EDT. Amid some rather impressive … WebApr 12, 2024 · Protagonist Therapeutics Inc (PTGX) stock is higher by 2.7% while the S&P 500 is lower by -0.03% as of 11:32 AM on Wednesday, Apr 12. PTGX is higher by $0.49 …
WebFind the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find out all the key statistics for Protagonist Therapeutics, Inc. (PTGX), including … See the company profile for Protagonist Therapeutics, Inc. (PTGX) including … Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or the "Company") today … Discover historical prices for PTGX stock on Yahoo Finance. View daily, weekly or … See Protagonist Therapeutics, Inc. (PTGX) stock analyst estimates, including … Get the detailed quarterly/annual income statement for Protagonist Therapeutics, … View the basic PTGX option chain and compare options of Protagonist … Get the latest Protagonist Therapeutics, Inc. (PTGX) stock news and headlines to help … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news … WebApr 13, 2024 · Dupont Capital Management Corp purchased a new stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Rating) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 13,127 shares of the company's stock, valued at approximately $143,000. A
WebPTGX Stock Quote Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield 1 day 5 days 10 days 1 month 3 …
WebApr 10, 2024 · A high-level overview of Protagonist Therapeutics, Inc. (PTGX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … the jump scareWebApr 13, 2024 · JMP Securities cut their target price on shares of Protagonist Therapeutics from $31.00 to $28.00 and set a “market outperform” rating on the stock in a research note on Thursday, March 16th. the jump pad costWebGet the latest Protagonist Therapeutics, Inc. (PTGX) stock news and headlines to help you in your trading and investing decisions. the jump yard strongsvilleWebApr 13, 2024 · 4 Wall Street research analysts have issued twelve-month target prices for Protagonist Therapeutics' stock. Their PTGX share price forecasts range from $28.00 to … the jump scare maze gameWebApr 10, 2024 · PTGX Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. the jump songWebApr 10, 2024 · Common Stock, par value $0.00001: PTGX: The Nasdaq Stock Market, LLC: ... (the "Common Stock"). The price to the public in this offering is $20.00 per share, and the Underwriters have agreed to purchase the shares from the Company pursuant to the Underwriting Agreement at a price of $18.80 per share. ... All news about PROTAGONIST … the jump zone hyderabadWebProtagonist Therapeutics Inc (NASDAQ: PTGX) shares are trading lower by 9.68% to $19.46 Wednesday morning after the company announced pricing of a $100 million public … the jump show